“Protein misfolding” diseases such as cystic fibrosis and Alzheimer’s may be seriously exacerbated by the body’s own response against that misfolding, according to a new study led by scientists at The Scripps Research Institute (TSRI).
The researchers examined patient cells and animal models of several diseases that feature chronic protein misfolding and found that in each case, a cellular defense system against protein misfolding, called the “heat shock response,” was overactive. Reducing its activity lessened the signs of disease and enhanced the effects of existing therapeutics.
“This has important implications for the treatment of many human diseases,” said TSRI Professor William E. Balch, PhD, who was senior investigator for the study.
The research, reported in November 18 by the journal PLoS Biology, focused initially on cystic fibrosis, a genetic disease that causes recurrent lung infections and cuts life expectancy in half.
Heat Shock Mystery
Nearly all cystic fibrosis patients have a particular mutation (a deletion of the amino acid phenylalanine at position 508, known as F508-del) in both copies of the gene that codes for CFTR, an ion-channel protein that normally helps regulate cellular chloride levels in the lungs and other tissues. Mutant CFTR protein is structurally unstable, tends to fold abnormally and thus usually ends up trapped by cellular “chaperone molecules” (folding helpers) in the interior of the cell, where it is degraded. Only a small percentage of the mutant CFTR protein reaches the cell membrane and functions as ion channels.
As Balch’s and other laboratories have shown in recent years, the chaperones that trap mutant CFTR are part of the heat shock response, a powerful system that evolved to defend cells against protein misfolding caused by excess heat, oxidation and other stress factors.
“The conventional view in the field of misfolding diseases for many years has been that boosting the heat shock response and chaperone levels to improve protein folding should be therapeutic in many protein-misfolding diseases,” said Daniela M. Roth, PhD, a research associate who led the study in the Balch laboratory. “That may not be the case when misfolded proteins are produced chronically, and the heat shock response stays elevated.”
In the new study, the team first confirmed that heat shocking bronchial epithelial cells—an important affected cell type in cystic fibrosis—leads to the near-total trapping and degradation of mutant CFTR. The scientists then reproduced the same increased-trapping effect at normal temperature by turning up the heat shock response artificially—via the overproduction of an active form of HSF1, a transcription factor protein that serves as the main “on switch” for the response.
The results showed that boosting the heat shock response probably would be detrimental in cystic fibrosis. But the scientists also found that cells harboring mutant CFTR develop an overactive heat shock response on their own—a response provoked simply by the presence of the misfolding CFTR proteins. When the scientists suppressed the production of mutant CFTR in the cells, indicators of the heat shock response fell back to normal.
The clear suggestion from all this was that dialing down the heat shock response could be beneficial, because it would reduce the overactivity of the chaperones that trap mutant CFTR. The team soon found that was the case: Inhibiting HSF1 activity reduced the chaperone trapping of mutant CFTR, allowing more of the protein to reach the cell membrane and thus better regulate chloride levels.
In further experiments, collaborator Jeffrey M. Beekman and his graduate student Johanna F. Dekkers at University Medical Centre, Utrecht, the Netherlands, used a cystic fibrosis model consisting of clumps of tissue—“organoids”—derived from cystic fibrosis patients. In these organoids, the scientists inhibited HSF1 with a compound called triptolide and at the same time applied VX-809, a promising cystic fibrosis drug candidate. The two drugs together showed a powerful synergistic effect, producing a greater reduction in disease signs, compared to VX-809 treatment on its own.
“It appears that having more heat shock chaperone activity exacerbates the signs of cystic fibrosis, whereas reducing that activity may be a way to treat the disease,” Roth said.
The team also found a hint that a chronically overactive heat shock response may end up causing a general disruption of the general folding function in cells. In cells containing mutant CFTR, but not in those with normal CFTR, a luminescent enzyme that marks the capacity of cells to enforce proper protein folding indicated a major reduction in global folding capacity.
“This broad impairment presumably reduces the ability of cells to function correctly in many folding reactions, which would compound the disease pathology,” said Balch.
Not Just Cystic Fibrosis
The finding that misfolded CFTR provokes an abnormal heat shock response, which seems to do more harm than good in cells, suggested to Balch and his colleagues that the same sort of thing might be happening in other protein-misfolding conditions.
The team confirmed that suspicion in cell models of the genetic disorders alpha-1-antitrypsin deficiency and Niemann-Pick disease. In both cases, cells that produced the mutant misfolded proteins showed signs of an overactive heat shock response—and inhibition of HSF1 improved markers of the mutant proteins’ functions.
Collaborator Richard I. Morimoto and his postdoctoral researcher Ning Wang at Northwestern University investigated a commonly used animal model of protein misfolding, in which a roundworm (C. elegans) overproduces the Alzheimer’s-associated amyloid beta 42 peptide in muscle cells. The worms’ muscle cells form aggregates of the peptide, and most of the affected worms develop paralysis. Again, HSF1 turned out to be overactive in these aggregate-filled muscle cells, and inhibiting HSF1 activity reduced the proportion of worms with paralysis, suggesting a strong evolutionary conservation of the maladaptive response.
To further establish the relevance to Alzheimer’s, collaborator Eliezer Masliah at the University of California, San Diego, looked at standard gene-mutant mouse models of the disease and found a similar HSF1 overactivation in brain tissue, compared to none in ordinary, wild-type mice.
“In general, it appears that the chronic production of misfolded proteins can lead to this ‘maladaptive stress response,’ as we call it,” said Balch. “Reducing the maladaptive stress response as a first line of defense could have an important impact on the progression and pathology in many diseases—from cancer to viral infections.”
In addition to Balch, Roth, Beekman, Dekkers, Morimoto, Wang and Masliah, co-authors of the paper, “Modulation of the Maladaptive Stress Response to Manage Diseases of Protein Folding,” were Darren M. Hutt, Jiansong Tong, Marion Bouchecareilh and Theo Seeley from TSRI; and Dan Garza and Lawrence Drew from Proteostasis Therapeutics, Inc.
This work was supported by the Cystic Fibrosis Foundation Therapeutics and by the National Institutes of Health (GM33301, GM42336, DK785483, AG031097 to Balch; AG031097, AG5131 and AG18440 to Masliah; M38109, GM81192, AG026647 to Morimoto); and the WKZ Research Fund and NCFS HIT-CF program to Beekman. Wang is an Alzheimer's Disease Foundation Fellow of the American Health Assistance Foundation. Roth is supported by Australia’s National Health and Medical Research Council CJ Martin fellowship, and Hutt was supported by fellowships from the Canadian Cystic Fibrosis Foundation and the Canadian Institutes for Health Research.
About the Scripps Research Institute
The Scripps Research Institute (TSRI) is one of the world's largest independent, not-for-profit organizations focusing on research in the biomedical sciences. TSRI is internationally recognized for its contributions to science and health, including its role in laying the foundation for new treatments for cancer, rheumatoid arthritis, hemophilia, and other diseases. An institution that evolved from the Scripps Metabolic Clinic founded by philanthropist Ellen Browning Scripps in 1924, the institute now employs about 3,000 people on its campuses in La Jolla, CA, and Jupiter, FL, where its renowned scientists—including three Nobel laureates—work toward their next discoveries. The institute's graduate program, which awards PhD degrees in biology and chemistry, ranks among the top ten of its kind in the nation. For more information, see www.scripps.edu
Madeline McCurry Schmidt | newswise
Rainbow colors reveal cell history: Uncovering β-cell heterogeneity
22.09.2017 | DFG-Forschungszentrum für Regenerative Therapien TU Dresden
The pyrenoid is a carbon-fixing liquid droplet
22.09.2017 | Max-Planck-Institut für Biochemie
Plants and algae use the enzyme Rubisco to fix carbon dioxide, removing it from the atmosphere and converting it into biomass. Algae have figured out a way to increase the efficiency of carbon fixation. They gather most of their Rubisco into a ball-shaped microcompartment called the pyrenoid, which they flood with a high local concentration of carbon dioxide. A team of scientists at Princeton University, the Carnegie Institution for Science, Stanford University and the Max Plank Institute of Biochemistry have unravelled the mysteries of how the pyrenoid is assembled. These insights can help to engineer crops that remove more carbon dioxide from the atmosphere while producing more food.
A warming planet
Our brains house extremely complex neuronal circuits, whose detailed structures are still largely unknown. This is especially true for the so-called cerebral cortex of mammals, where among other things vision, thoughts or spatial orientation are being computed. Here the rules by which nerve cells are connected to each other are only partly understood. A team of scientists around Moritz Helmstaedter at the Frankfiurt Max Planck Institute for Brain Research and Helene Schmidt (Humboldt University in Berlin) have now discovered a surprisingly precise nerve cell connectivity pattern in the part of the cerebral cortex that is responsible for orienting the individual animal or human in space.
The researchers report online in Nature (Schmidt et al., 2017. Axonal synapse sorting in medial entorhinal cortex, DOI: 10.1038/nature24005) that synapses in...
Whispering gallery mode (WGM) resonators are used to make tiny micro-lasers, sensors, switches, routers and other devices. These tiny structures rely on a...
Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!
When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...
For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.
Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...
19.09.2017 | Event News
12.09.2017 | Event News
06.09.2017 | Event News
22.09.2017 | Life Sciences
22.09.2017 | Medical Engineering
22.09.2017 | Physics and Astronomy